shenzhen salubris pharmaceuticals co., ltd.-乐鱼全站app

 shenzhen salubris pharmaceuticals co., ltd.-乐鱼全站app

collaborating with global innovative resources,
studying pathogenic mechanisms, exploring treatment methods and developing innovative drugs

scientific research topics

a new treatment of renal anemia

license-in sal0951, an innovative drug for renal anemia

learn more

efficient and collaborative r&d centers

group research institute (shenzhen)

focusing on the discovery and development of small molecule innovative drugs, the institute has a highly talented r&d team led by returnees. we have built a sound medical development, operation, data management and statistics system, pv and quality a

r&d institute (chengdu)

focusing on the research and development of innovative biologics and biosimilars.; early discovery platforms: antibody screening and optimization, cho-gs eukaryotic expression system, as well as complete cmc development system, including cell line

group research institute (usa)

located in maryland, usa, it has gathered a number of well-known new drug experts, who devote themselves to the early research and development of innovative drugs and carry out research on new biopharmaceuticals with global independent intellectual p

r&d platform

learn more

r&d pipeline

learn more
网站地图